|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4000 USD | +3.73% |
|
+8.23% | -65.96% |
| 06-25 | BioRestorative Therapies Completes Manufacturing for BRTX-100 Phase 2 Clinical Trial | CI |
| 06-15 | BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired. | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 0.479 | 1.22 | 0.5947 |
| Spread/Res. | -16.49% | -67.21% | -32.74% |
| Spread/Supp. | +51.69% | +135.57% | +108.12% |
| Support | 0.2637 | 0.1698 | 0.1922 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BRTX Stock
- Charts BioRestorative Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
